Neuroscience · Year 2 · from Neuroscience
Case 3: Botulism - Presynaptic Neuromuscular Blockade
Patient Presentation
Demographics: 26-year-old male
Chief Complaint: Blurred vision, difficulty swallowing, and weakness for 12 hours
History of Present Illness: A 26-year-old man presents to the emergency department with rapidly progressive symptoms that began yesterday evening. He first noticed blurred vision and drooping eyelids, followed by difficulty swallowing and speaking clearly. Over the past several hours, he has developed arm and leg weakness. He ate home-canned green beans at a family gathering 36 hours ago. Several other family members who ate the same dish are also ill with similar symptoms.
Physical Examination:
- Vital signs: BP 110/70, HR 92, RR 22, T 37.0C, SpO2 94% on room air
- General: Alert, anxious-appearing, weak voice
- Neurological:
- Mental status: Alert, oriented (cognition preserved)
- Cranial nerves: Bilateral ptosis; sluggish pupillary responses; complete ophthalmoplegia; facial weakness; absent gag reflex; weak tongue protrusion
- Motor: 3/5 proximal, 4/5 distal strength in all extremities; symmetric
- Sensory: Intact to all modalities
- Reflexes: Diminished throughout (1+)
- Respiratory: Shallow breathing, weak cough, negative inspiratory force -25 cmH2O (concerning)
Workup:
- Serum botulinum toxin assay: Positive for Clostridium botulinum toxin type A (results returned 48 hours later)
- EMG/nerve conduction: Low CMAP amplitudes with incremental response to rapid repetitive stimulation
- Stool culture: Positive for Clostridium botulinum
- Analysis of remaining canned goods: Positive for botulinum toxin
- CSF analysis: Normal (excluding Guillain-Barre syndrome)
Diagnosis: Foodborne botulism
Treatment:
- Immediate intubation and mechanical ventilation for respiratory failure
- Heptavalent botulism antitoxin administered within 24 hours of presentation
- ICU admission with continuous monitoring
- Notification of public health authorities
- Supportive care through prolonged recovery (weeks to months)
- Other affected family members treated similarly
Clinical Pearl: Botulinum toxin blocks neuromuscular transmission by cleaving SNARE proteins (SNAP-25, synaptobrevin, syntaxin) essential for synaptic vesicle fusion with the presynaptic membrane. Without vesicle fusion, acetylcholine cannot be released, causing flaccid paralysis. Unlike myasthenia gravis (postsynaptic) or LEMS (calcium channel), botulism targets the vesicle release machinery directly. The toxin's extraordinary potency explains its use as both a bioweapon concern and a therapeutic agent (at minuscule doses) for dystonia and cosmetic applications.
Clinical Image
Image Description: Electron micrograph of the neuromuscular junction showing the presynaptic terminal with synaptic vesicles containing acetylcholine, the synaptic cleft, and the postsynaptic membrane with junctional folds containing nicotinic acetylcholine receptors.
Attribution: Image from Wikimedia Commons (https://commons.wikimedia.org/), Creative Commons license.